A detailed history of Ronald Blue Trust, Inc. transactions in Nevro Corp stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 18 shares of NVRO stock, worth $74. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18
Previous 16 12.5%
Holding current value
$74
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$4.71 - $10.1 $9 - $20
2 Added 12.5%
18 $0
Q2 2024

Jul 18, 2024

BUY
$7.96 - $13.59 $127 - $217
16 New
16 $0
Q4 2023

Jan 18, 2024

BUY
$14.18 - $22.31 $709 - $1,115
50 New
50 $1,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $147M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Ronald Blue Trust, Inc. Portfolio

Follow Ronald Blue Trust, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ronald Blue Trust, Inc. with notifications on news.